the Company’s registered capital from 322,500,000 THB to 377,500,000THB per share, for the allotment of newly issued ordinary shares to specific investors (Private Placement) for the compensation of
firms share our views and objectives and have made much progress in resolving their deficiencies, with the exception of few findings whose remedies are time consuming in nature. The mechanics of how audit
Distribution of Newly Issued Shares and Share Warrants by Issuer
from the loss in the business of personal loan, mobile phone, and hire purchase. The Company was therefore aware of the problem and decided to resolve so that the future performance returned to normal as
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
THB to 377,500,000THB per share, for the allotment of newly i of entire business transfer of FKRMM, and the amendment to Clause with the increase of the Company’s registered capital. T “Clause 4
ละเอียดลูกหนี้ที่มีปัญหา (problem loans) ทั้งบัญชี cash และ margin 5.1 มูลหนี้รวม ............................................. ล้านบาท 5.2 จำนวนราย .............................................. ราย 5.3
: ล้านบาท ขอ้ 5 รำยละเอียดลูกหน้ีท่ีมีปัญหำ (problem loans) ทั้งบญัชี cash และ margin 5.1 มูลหน้ีรวม ............................................. ลำ้นบำท 5.2 จ ำนวนรำย
net loss of Baht 12.54 million on Baht 55.25 million revenues over the same period in 2017. In 2018 the Company recorded lower revenues from sales, due to the raw material supply problem, and recorded